Recordati Rare Diseases North America
Nathan Gough Pineda is a seasoned marketing professional with a robust background in brand management across the pharmaceutical and healthcare sectors. Currently serving as Brand Manager for UK & IRE at Recordati Rare Diseases Inc. since March 2023, Nathan has previously held key roles including Director at NWG Pharma Assoc. Ltd., Omnichannel Brand Lead at Amicus Therapeutics, and Brand Manager at AstraZeneca. With expertise in product strategy, marketing execution, and stakeholder collaboration, Nathan has successfully contributed to the development and launch of various medical products, including a multivitamin for Cystic Fibrosis patients in the UK. Nathan's academic credentials include a Master's Degree in Biochemistry from the University of Southampton and a Diploma in Professional Marketing from Oxford College of Marketing.
This person is not in any offices
Recordati Rare Diseases North America
1 followers
Recordati Rare Diseases Inc. (RRD) markets products to treat rare diseases. RRD is a member of the Recordati Group, which includes Recordati S.p.A., Orphan Europe, among other companies around the globe. The Recordati Group, which was established in 1926 currently employs more than 4,000 worldwide. The RRD mission is to reduce the impact of extremely rare and devastating diseases by providing urgently needed therapies. We work side-by-side with rare disease communities to increase awareness, improve diagnosis and expand availability of treatments for people with rare diseases.